ARTIVION INC (AORT)

US2289031005 - Common Stock

27.88  -0.2 (-0.71%)

After market: 27.88 0 (0%)

ARTIVION INC

NYSE:AORT (1/3/2025, 8:20:01 PM)

After market: 27.88 0 (0%)

27.88

-0.2 (-0.71%)

Chartmill TA Rating
Chartmill Setup Rating
Sector
GICS SectorHealth Care
GICS IndustryHealth Care Equipment & Supplies
GICS SubIndustryHealth Care Equipment
Chartmill FA Rating
Valuation
Growth
Profitability
Health
Dividend
Chartmill High Growth Momentum
EPS Q2Q%79.17%
Sales Q2Q%9.02%
CRS89.37
6 Month10.33%
Overview
Earnings (Last)11-07 2024-11-07/amc
Earnings (Next)02-13 2025-02-13/amc
Ins Owners5.51%
Inst Owners79.5%
Market Cap1.17B
Shares41.92M
PEN/A
Fwd PE197.6
Dividend YieldN/A
Analysts86.67
Short Float %9.36%
Short Ratio14.35
IPO02-12 1993-02-12
Stock Screener Links
Screen Image

New York Stock Exchange, Inc. Stock Screener

Find more stocks on New York Stock Exchange, Inc.

Screen Image

USA Stock Screener

Find more stocks on the USA

Screen Image

GICS Sector Stock Screener

Find competitors from the same sector on the USA

Screen Image

GICS Industry Stock Screener

Find competitors from the same industry on the USA

Screen Image

Technical Stock Screener

Find stocks with similar TA and Setup ratings on the USA

Screen Image

Fundamental Stock Screener

Find stocks with similar Fundamental rating on the USA

Screen Image

Best Technical Competitors Stock Screener

Find the competitors with the best technical ratings on the USA

Screen Image

Best Technical Setups Competitors Stock Screener

Find the competitors with the best technical and setup ratings on the USA

Screen Image

Best Fundamental Competitors Stock Screener

Find the competitors with the best fundamentals on the USA

Screen Image

Best Valuation Competitors Stock Screener

Find the competitors with the best valuation on the USA

Screen Image

Best Dividend Competitors Stock Screener

Find the competitors with the best dividend on the USA

Screen Image

Best Analyst Rating Competitors Stock Screener

Find the competitors with the best analyst ratings on the USA

AORT Daily chart

Company Profile

Artivion, Inc. engages in the research and development of solutions which address cardiac and vascular surgeons' clinical challenges in treating patients with aortic diseases. The company is headquartered in Kennesaw, Georgia and currently employs 1,500 full-time employees. The firm's segments include Medical Devices and Preservation Services. The Medical Devices segment includes sales of aortic stent grafts, surgical sealants, and On-X. The Preservation Services segment includes services for the preservation of cardiac and vascular implantable human tissues. The company has four product families: aortic stent grafts, surgical sealants, On-X mechanical heart valves and related surgical products, and implantable cardiac and vascular human tissues. Aortic stent grafts include aortic arch stent grafts, abdominal stent grafts, and synthetic vascular grafts. Surgical sealants include BioGlue Surgical Adhesive products. The company also sells or distributes PhotoFix bovine surgical patches.

Company Info

ARTIVION INC

1655 Roberts Boulevard N W

Kennesaw GEORGIA

P: 17704193355

Employees: 1500

Website: https://artivion.com/

AORT News

News Image2 months ago - Artivion, Inc.Artivion Reports Third Quarter 2024 Financial Results

Third Quarter Highlights: Achieved revenue of $95.8 million in the third quarter of 2024 versus $87.9 million in the third quarter of 2023, an increase of 9%...

News Image2 months ago - Artivion, Inc.Artivion to Participate in Upcoming Investor Conferences

/PRNewswire/ -- Artivion, Inc. (NYSE: AORT), a leading cardiac and vascular surgery company focused on aortic disease, today announced that it will participate...

News Image2 months ago - Artivion, Inc.Artivion Announces Release Date and Teleconference Call Details for Third Quarter 2024 Financial Results

/PRNewswire/ -- Artivion, Inc. (NYSE: AORT), a leading cardiac and vascular surgery company focused on aortic disease, announced today that third quarter 2024...

News Image3 months ago - Artivion, Inc.Artivion Announces Presentation of Late-Breaking Clinical Data at the 38th European Association for Cardio-Thoracic Surgery (EACTS) Annual Meeting

/PRNewswire/ -- Artivion, Inc. (NYSE: AORT), a leading cardiac and vascular surgery company focused on aortic disease, today announced data from its AMDS DARTS...

News Image5 months ago - InvestorPlaceAORT Stock Earnings: Artivion Beats EPS, Beats Revenue for Q2 2024

AORT stock results show that Artivion beat analyst estimates for earnings per share and beat on revenue for the second quarter of 2024.

News Image5 months ago - BusinessInsiderAORT Stock Earnings: Artivion Beats EPS, Beats Revenue for Q2 2024

InvestorPlace - Stock Market News, Stock Advice & Trading Tips Artivion (NYSE:AORT) just reported results for the second quarter of 2024.Artiv...

AORT Twits

Here you can normally see the latest stock twits on AORT, but your cookie settings prevent this from loading. You can edit your cookie settings in our cookie consent dialog.

Example Twits:

Twits example